Search Results

There are 3037 results for: content related to: Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013

  1. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009

    Bipolar Disorders

    Volume 11, Issue 3, May 2009, Pages: 225–255, Lakshmi N Yatham, a Sidney H Kennedy, b Ayal Schaffer, b Sagar V Parikh, b Serge Beaulieu, c Claire O'Donovan, d Glenda MacQueen, e Roger S McIntyre, b Verinder Sharma, f Arun Ravindran, b L Trevor Young, a Allan H Young, a Martin Alda, d Roumen Milev, g Eduard Vieta, h Joseph R Calabrese, i Michael Berk, j Kyooseob Ha and k Flávio Kapczinski l

    Version of Record online : 14 APR 2009, DOI: 10.1111/j.1399-5618.2009.00672.x

  2. Efficacy of antimanic treatments in mixed states

    Bipolar Disorders

    Volume 14, Issue s2, May 2012, Pages: 22–36, Roger S McIntyre and Jinju Yoon

    Version of Record online : 17 APR 2012, DOI: 10.1111/j.1399-5618.2012.00990.x

  3. Oral paliperidone for schizophrenia

    Intervention Review

    The Cochrane Library

    Abraham M Nussbaum and T S Stroup

    Published Online : 23 APR 2008, DOI: 10.1002/14651858.CD006369.pub2

  4. A randomized, placebo- and active-controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder

    Bipolar Disorders

    Volume 12, Issue 3, May 2010, Pages: 230–243, Eduard Vieta, Isaac F Nuamah, Pilar Lim, Eric C Yuen, Joseph M Palumbo, David W Hough and Joris Berwaerts

    Version of Record online : 10 MAY 2010, DOI: 10.1111/j.1399-5618.2010.00815.x

  5. Risperidone and Paliperidone in the Treatment of Bipolar Disorder

    Bipolar Psychopharmacotherapy: Caring for the Patient, Second Edition

    L. Ivo Caers, Joris Berwaerts, Pages: 153–192, 2011

    Published Online : 13 APR 2011, DOI: 10.1002/9780470975114.ch9

  6. Paliperidone palmitate for schizophrenia

    Intervention Review

    The Cochrane Library

    Abraham M Nussbaum and T S Stroup

    Published Online : 13 JUN 2012, DOI: 10.1002/14651858.CD008296.pub2

  7. Paliperidone Extended-Release for the Treatment of Schizophrenia

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 10, October 2008, Pages: 1283–1298, Jehan Marino and Joshua Caballero

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.28.10.1283

  8. Single- and Multiple-Dose Pharmacokinetics and Dose Proportionality of the Psychotropic Agent Paliperidone Extended Release

    The Journal of Clinical Pharmacology

    Volume 49, Issue 11, November 2009, Pages: 1318–1330, Dr Sandra Boom, Dr Krishna Talluri, Mr Luc Janssens, Dr Bart Remmerie, Dr Marc De Meulder, Dr Stefaan Rossenu, Dr Nancy van Osselaer, Dr Marielle Eerdekens and Dr Adriaan Cleton

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009339190

  9. You have free access to this content
    Signalling profile differences: paliperidone versus risperidone

    British Journal of Pharmacology

    Volume 170, Issue 3, October 2013, Pages: 532–545, W P Clarke, T A Chavera, M Silva, L C Sullivan and K A Berg

    Version of Record online : 17 SEP 2013, DOI: 10.1111/bph.12295

  10. You have free access to this content
    Paliperidone palmitate – review of the efficacy, safety and cost of a new second-generation depot antipsychotic medication

    International Journal of Clinical Practice

    Volume 64, Issue 2, January 2010, Pages: 216–239, L. Citrome

    Version of Record online : 3 NOV 2009, DOI: 10.1111/j.1742-1241.2009.02240.x

  11. Poster Sessions

    Bipolar Disorders

    Volume 9, Issue s1, June 2007, Pages: 13–116,

    Version of Record online : 9 MAY 2007, DOI: 10.1111/j.1399-5618.2007.00511.x

  12. Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorder

    Bipolar Disorders

    Volume 14, Issue s2, May 2012, Pages: 1–21, Gin S Malhi, Danielle M Bargh, Roger McIntyre, Michael Gitlin, Mark A Frye, Michael Bauer and Michael Berk

    Version of Record online : 17 APR 2012, DOI: 10.1111/j.1399-5618.2012.00989.x

  13. Quetiapine in Bipolar Disorder

    Bipolar Psychopharmacotherapy: Caring for the Patient, Second Edition

    Mauricio Kunz, Svante Nyberg, Lakshmi N. Yatham, Pages: 193–222, 2011

    Published Online : 13 APR 2011, DOI: 10.1002/9780470975114.ch10

  14. You have free access to this content
    Paliperidone: quo vadis?

    International Journal of Clinical Practice

    Volume 61, Issue 4, April 2007, Pages: 653–662, L. Citrome

    Version of Record online : 2 MAR 2007, DOI: 10.1111/j.1742-1241.2007.01321.x

  15. The clinical management of bipolar disorder complexity using a stratified model

    Bipolar Disorders

    Volume 14, Issue s2, May 2012, Pages: 66–89, Gin S Malhi, Danielle M Bargh, Emma Cashman, Mark A Frye and Michael Gitlin

    Version of Record online : 17 APR 2012, DOI: 10.1111/j.1399-5618.2012.00993.x

  16. Paliperidone in the treatment of delirium: results of a prospective open-label pilot trial

    Acta Neuropsychiatrica

    Volume 23, Issue 4, August 2011, Pages: 179–183, Ho-Kyoung Yoon, Yong-Ku Kim, Changsu Han, Young-Hoon Ko, Heon-Jeong Lee, Do-Young Kwon and Leen Kim

    Version of Record online : 23 MAY 2011, DOI: 10.1111/j.1601-5215.2011.00568.x

  17. You have free access to this content
    Studies on the Acute Toxicity, Pharmacokinetics and Pharmacodynamics of Paliperidone Derivatives – Comparison to Paliperidone and Risperidone in Mice and Rats

    Basic & Clinical Pharmacology & Toxicology

    Volume 107, Issue 2, August 2010, Pages: 656–662, Fengying Sun, Zhengxing Su, Cheng Sui, Chao Zhang, Lijia Yuan, Qingfan Meng, Lirong Teng and Youxin Li

    Version of Record online : 25 MAR 2010, DOI: 10.1111/j.1742-7843.2010.00552.x

  18. What are the nursing implications when using paliperidone prolonged release for people with schizophrenia

    Journal of Psychiatric and Mental Health Nursing

    Volume 15, Issue 10, December 2008, Pages: 792–799, A. JONES

    Version of Record online : 4 NOV 2008, DOI: 10.1111/j.1365-2850.2008.01299.x

  19. Modeling the Effectiveness of Paliperidone ER and Olanzapine in Schizophrenia: Meta-Analysis of 3 Randomized, Controlled Clinical Trials

    The Journal of Clinical Pharmacology

    Volume 50, Issue 3, March 2010, Pages: 293–310, Ignacio Ortega, Juan Jose Perez-Ruixo, Kim Stuyckens, Vladimir Piotrovsky and An Vermeulen

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009346057

  20. Table of Contents

    The Brown University Psychopharmacology Update

    Volume 18, Issue 3, March 2007, Pages: 1–8,

    Version of Record online : 23 FEB 2007, DOI: 10.1002/pu.20039